Table 1 Literature inclusion and exclusion criteria

Selection criteria

 Inclusion

  (1) Topic of study: human cancer

  (2) Diagnosis method: pathology or histology

  (3) Detected method of SNHG16: qRT-PCR, ISH, or other methods in tissues

  (4) Patients divided into “high SNHG16” and “low SNHG16” groups

  (5) Association between SNHG16 and clinicopathological and prognostic features^a: clearly reported

  (6) HR and 95% CIs: acquired or estimated

 Exclusion

  (1) Literature type: reviews, case reports, meeting abstracts, and basic experimental research literature

  (2) Duplicate articles or data

  (3) Publication language: other than English